ORIGINAL ARTICLE

Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1

F J Fleming^1,4, E Myers^1,4, G Kelly², T B Crotty³, E W McDermott¹, N J O’Higgins¹, A D K Hill^1,3,4 and L S Young^1,4

¹ Department of Surgery, Saint Vincent’s University Hospital, Elm Park, Dublin 4, Ireland
² The Department of Statistics, University College Dublin, Dublin 4, Ireland
³ Department of Pathology, Saint Vincent’s University Hospital
⁴ The Conway Institute, University College Dublin

Correspondence to:
Correspondence to:
Dr L S Young
Department of Surgery, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland; leonie.young{at}ucd.ie

Background: In human breast cancer, the growth factor receptor HER2 is associated with disease progression and resistance to endocrine treatment. Growth factor induced mitogen activated protein kinase activity can phosphorylate not only the oestrogen receptor, but also its coactivator proteins AIB1 and SRC-1.

Aim: To determine whether insensitivity to endocrine treatment in HER2 positive patients is associated with enhanced expression of coactivator proteins, expression of the HER2 transcriptional regulator, PEA3, and coregulatory proteins, AIB1 and SRC-1, was assessed in a cohort of patients with breast cancer of known HER2 status.

Methods: PEA3, AIB1, and SRC-1 protein expression in 70 primary breast tumours of known HER2 status (HER2 positive, n = 35) and six reduction mammoplasties was assessed using immunohistochemistry. Colocalisation of PEA3 with AIB1 and SRC-1 was determined using immunofluorescence. Expression of PEA3, AIB1, and SRC-1 was correlated with clinicopathological parameters.

Results: In primary breast tumours expression of PEA3, AIB1, and SRC-1 was associated with HER2 status (p = 0.0486, p = 0.0444, and p = 0.0012, respectively). In the HER2 positive population, PEA3 expression was associated with SRC-1 (p = 0.0354), and both PEA3 and SRC-1 were significantly associated with recurrence on univariate analysis (p = 0.0345; p<0.0001). On multivariate analysis, SRC-1 was significantly associated with disease recurrence in HER2 positive patients (p = 0.0066).

Conclusion: Patients with high expression of HER2 in combination with SRC-1 have a greater probability of recurrence on endocrine treatment compared with those who are HER2 positive but SRC-1 negative. SRC-1 may be an important predictive indicator and therapeutic target in breast cancer.

Abbreviations: AIB1, amplified in breast cancer 1; EGFR, epidermal growth factor receptor; ER, oestrogen receptor; MAP, mitogen activated protein; PBS, phosphate buffered saline; SRC-1, steroid receptor coactivator-1

Keywords: breast cancer; HER2; PEA3; SRC-1; coactivators

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Heck, S., Rom, J., Thewes, V., Becker, N., Blume, B., Sinn, H. P., Deuschle, U., Sohn, C., Schneeweiss, A., Lichter, P. (2009). Estrogen-Related Receptor {alpha} Expression and Function Is Associated with the Transcriptional Coregulator AIB1 in Breast Carcinoma. Cancer Res. 69: 5186-5193 [Abstract] [Full Text]  
• Qin, L., Liu, Z., Chen, H., Xu, J. (2009). The Steroid Receptor Coactivator-1 Regulates Twist Expression and Promotes Breast Cancer Metastasis. Cancer Res. 69: 3819-3827 [Abstract] [Full Text]  
• Redmond, A. M., Bane, F. T., Stafford, A. T., McIlroy, M., Dillon, M. F., Crotty, T. B., Hill, A. D., Young, L. S. (2009). Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence. Clin. Cancer Res. 15: 2098-2106 [Abstract] [Full Text]  
• Wang, S., Yuan, Y., Liao, L., Kuang, S.-Q., Tien, J. C.-Y., O'Malley, B. W., Xu, J. (2009). Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation. Proc. Natl. Acad. Sci. USA 106: 151-156 [Abstract] [Full Text]  
• Firlej, V., Ladam, F., Brysbaert, G., Dumont, P., Fuks, F., de Launoit, Y., Benecke, A., Chotteau-Lelievre, A. (2008). Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription. J. Cell Sci. 121: 3393-3402 [Abstract] [Full Text]  
• Qin, L., Liao, L., Redmond, A., Young, L., Yuan, Y., Chen, H., O'Malley, B. W., Xu, J. (2008). The AIB1 Oncogene Promotes Breast Cancer Metastasis by Activation of PEA3-Mediated Matrix Metalloproteinase 2 (MMP2) and MMP9 Expression. Mol. Cell. Biol. 28: 5937-5950 [Abstract] [Full Text]  
• Bartlett, J. M.S., Ellis, I. O., Dowsett, M., Mallon, E. A., Cameron, D. A., Johnston, S., Hall, E., A'Hern, R., Peckitt, C., Bliss, J. M., Johnson, L., Barrett-Lee, P., Ellis, P. (2007). Human Epidermal Growth Factor Receptor 2 Status Correlates With Lymph Node Involvement in Patients With Estrogen Receptor (ER) Negative, but With Grade in Those With ER-Positive Early-Stage Breast Cancer Suitable for Cytotoxic Chemotherapy. JCO 25: 4423-4430 [Abstract] [Full Text]  
• Yuan, Y., Xu, J. (2007). Loss-of-Function Deletion of the Steroid Receptor Coactivator-1 Gene in Mice Reduces Estrogen Effect on the Vascular Injury Response. Arterioscler. Thromb. Vasc. Bio. 27: 1521-1527 [Abstract] [Full Text]  
• Mc Ilroy, M., Fleming, F. J, Buggy, Y., Hill, A. D K, Young, L. S (2006). Tamoxifen-induced ER-{alpha}-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence. Endocr Relat Cancer 13: 1135-1145 [Abstract] [Full Text]  
• Kishimoto, H., Wang, Z., Bhat-Nakshatri, P., Chang, D., Clarke, R., Nakshatri, H. (2005). The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1{alpha}/CXCL12. Carcinogenesis 26: 1706-1715 [Abstract] [Full Text]  
• Kuang, S.-Q., Liao, L., Wang, S., Medina, D., O'Malley, B. W., Xu, J. (2005). Mice Lacking the Amplified in Breast Cancer 1/Steroid Receptor Coactivator-3 Are Resistant to Chemical Carcinogen-Induced Mammary Tumorigenesis. Cancer Res. 65: 7993-8002 [Abstract] [Full Text]  
• Myers, E., Hill, A. D.K., Kelly, G., McDermott, E. W., O'Higgins, N. J., Buggy, Y., Young, L. S. (2005). Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast Cancer. Clin. Cancer Res. 11: 2111-2122 [Abstract] [Full Text]